_id
6911c86accc777a4e85d6663
Ticker
HUMAW
Name
Humacyte Inc
Exchange
NASDAQ
Address
2525 East North Carolina Highway 54, Durham, NC, United States, 27713
Country
USA
Sector
Industry
Currency
USD
Website
https://humacyte.com
Description
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Last Close
0.23
Volume
3320
Current Price
0.1499
Change
3.894736842105258
Last Updated
2026-01-04T14:47:45.842Z
Image
data:image/webp;base64,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
Ipo Date
2020-11-24T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
-
Target Price
-
Strong Buy
-
Buy
-
Hold
-
Sell
-
Strong Sell
-
Current Quarter
2025-09-30
Revenue
753000
Cost Of Revenue
260000
Gross Profit
493000
Operating Expenses
24883000
Operating Income
-24390000
Interest Expense
2612000
Pretax Income
-17510000
Net Income
-17510000
Eps
-0.11060347491988828
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-13033000
Operating Margin
-3239.043824701195
Total Other Income Expense Net
6880000
Cash
19488000
Short Term Investments
-
Receivables
1078000
Inventories
18418000
Total Current Assets
41351000
Property Plant Equipment
49277000
Total Assets
91509000
Payables
9575000
Short Term Debt
2670000
Long Term Debt
-
Total Liabilities
96260000
Equity
-4751000
Bs_currency_symbol
USD
Depreciation
1865000
Change In Working Capital
-4121000
Cash From Operations
-23904000
Capital Expenditures
49000
Cash From Investing
-49000
Cash From Financing
-44591000
Net Change In Cash
-68544000
Cf_currency_symbol
USD
PE
-
PB
-4.994982565986108
ROE
368.5539886339718
ROA
-19.134729917275898
FCF
-23953000
Fcf Percent
-31.810092961487385
Piotroski FScore
0
Health Score
30
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
4
Net Net Investing Score
0
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
753000
Quarters > 0 > income Statement > cost Of Revenue
260000
Quarters > 0 > income Statement > gross Profit
493000
Quarters > 0 > income Statement > operating Expenses
24883000
Quarters > 0 > income Statement > operating Income
-24390000
Quarters > 0 > income Statement > interest Expense
2612000
Quarters > 0 > income Statement > pretax Income
-17510000
Quarters > 0 > income Statement > net Income
-17510000
Quarters > 0 > income Statement > eps
-0.11060347491988828
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
158313290
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13033000
Quarters > 0 > income Statement > operating Margin
-3239.043824701195
Quarters > 0 > income Statement > total Other Income Expense Net
6880000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
19488000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1078000
Quarters > 0 > balance Sheet > inventories
18418000
Quarters > 0 > balance Sheet > total Current Assets
41351000
Quarters > 0 > balance Sheet > property Plant Equipment
49277000
Quarters > 0 > balance Sheet > total Assets
91509000
Quarters > 0 > balance Sheet > payables
9575000
Quarters > 0 > balance Sheet > short Term Debt
2670000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
96260000
Quarters > 0 > balance Sheet > equity
-4751000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-17510000
Quarters > 0 > cash Flow > depreciation
1865000
Quarters > 0 > cash Flow > change In Working Capital
-4121000
Quarters > 0 > cash Flow > cash From Operations
-23904000
Quarters > 0 > cash Flow > capital Expenditures
49000
Quarters > 0 > cash Flow > cash From Investing
-49000
Quarters > 0 > cash Flow > cash From Financing
-44591000
Quarters > 0 > cash Flow > net Change In Cash
-68544000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.11060347491988828
Quarters > 0 > ratios > PB
-4.994982565986108
Quarters > 0 > ratios > ROE
368.5539886339718
Quarters > 0 > ratios > ROA
-19.134729917275898
Quarters > 0 > ratios > FCF
-23953000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-31.810092961487385
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
301000
Quarters > 1 > income Statement > cost Of Revenue
2073000
Quarters > 1 > income Statement > gross Profit
-1772000
Quarters > 1 > income Statement > operating Expenses
27955000
Quarters > 1 > income Statement > operating Income
-29727000
Quarters > 1 > income Statement > interest Expense
2545000
Quarters > 1 > income Statement > pretax Income
-37658000
Quarters > 1 > income Statement > net Income
-37658000
Quarters > 1 > income Statement > eps
-0.2422713505905961
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
155437281
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-33253000
Quarters > 1 > income Statement > operating Margin
-9876.079734219269
Quarters > 1 > income Statement > total Other Income Expense Net
-7931000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
38032000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
394000
Quarters > 1 > balance Sheet > inventories
11067000
Quarters > 1 > balance Sheet > total Current Assets
51730000
Quarters > 1 > balance Sheet > property Plant Equipment
35634000
Quarters > 1 > balance Sheet > total Assets
138795000
Quarters > 1 > balance Sheet > payables
6629000
Quarters > 1 > balance Sheet > short Term Debt
5209000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
134743001
Quarters > 1 > balance Sheet > equity
4051999
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-37658000
Quarters > 1 > cash Flow > depreciation
1860000
Quarters > 1 > cash Flow > change In Working Capital
-1398000
Quarters > 1 > cash Flow > cash From Operations
-26413000
Quarters > 1 > cash Flow > capital Expenditures
568000
Quarters > 1 > cash Flow > cash From Investing
-568000
Quarters > 1 > cash Flow > cash From Financing
2166000
Quarters > 1 > cash Flow > net Change In Cash
-24959000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.2422713505905961
Quarters > 1 > ratios > PB
5.75026016094772
Quarters > 1 > ratios > ROE
-929.3684425884607
Quarters > 1 > ratios > ROA
-27.13210130047912
Quarters > 1 > ratios > FCF
-26981000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-89.63787375415282
Quarters > 1 > health Score
12
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
517000
Quarters > 2 > income Statement > cost Of Revenue
1979000
Quarters > 2 > income Statement > gross Profit
-1462000
Quarters > 2 > income Statement > operating Expenses
21722000
Quarters > 2 > income Statement > operating Income
-23184000
Quarters > 2 > income Statement > interest Expense
3000000
Quarters > 2 > income Statement > pretax Income
39139000
Quarters > 2 > income Statement > net Income
39139000
Quarters > 2 > income Statement > eps
0.29704923603799904
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
131759302
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
43971000
Quarters > 2 > income Statement > operating Margin
-4484.332688588008
Quarters > 2 > income Statement > total Other Income Expense Net
62323000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
62847000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
488000
Quarters > 2 > balance Sheet > inventories
8020000
Quarters > 2 > balance Sheet > total Current Assets
73705000
Quarters > 2 > balance Sheet > property Plant Equipment
37402000
Quarters > 2 > balance Sheet > total Assets
162553000
Quarters > 2 > balance Sheet > payables
5572000
Quarters > 2 > balance Sheet > short Term Debt
3006000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
126510000
Quarters > 2 > balance Sheet > equity
36043000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
39139000
Quarters > 2 > cash Flow > depreciation
1832000
Quarters > 2 > cash Flow > change In Working Capital
-9564000
Quarters > 2 > cash Flow > cash From Operations
-28601000
Quarters > 2 > cash Flow > capital Expenditures
228000
Quarters > 2 > cash Flow > cash From Investing
-228000
Quarters > 2 > cash Flow > cash From Financing
46739000
Quarters > 2 > cash Flow > net Change In Cash
17910000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.29704923603799904
Quarters > 2 > ratios > PB
0.5479765660405627
Quarters > 2 > ratios > ROE
108.58974003273867
Quarters > 2 > ratios > ROA
24.07768543182839
Quarters > 2 > ratios > FCF
-28829000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-55.76208897485493
Quarters > 2 > health Score
55
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7228000
Quarters > 3 > income Statement > cost Of Revenue
3614000
Quarters > 3 > income Statement > gross Profit
3614000
Quarters > 3 > income Statement > operating Expenses
31702000
Quarters > 3 > income Statement > operating Income
-28088000
Quarters > 3 > income Statement > interest Expense
2508000
Quarters > 3 > income Statement > pretax Income
-20940000
Quarters > 3 > income Statement > net Income
-20940000
Quarters > 3 > income Statement > eps
-0.17674003710544822
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
118479097
Quarters > 3 > income Statement > income Tax Expense
-1747724
Quarters > 3 > income Statement > EBITDA
-16624000
Quarters > 3 > income Statement > operating Margin
-388.5998893193138
Quarters > 3 > income Statement > total Other Income Expense Net
7148000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
44937000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
47859000
Quarters > 3 > balance Sheet > property Plant Equipment
38553000
Quarters > 3 > balance Sheet > total Assets
137872000
Quarters > 3 > balance Sheet > payables
4490000
Quarters > 3 > balance Sheet > short Term Debt
2917000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
190541000
Quarters > 3 > balance Sheet > equity
-52669000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-20940000
Quarters > 3 > cash Flow > depreciation
-322000
Quarters > 3 > cash Flow > change In Working Capital
-2812000
Quarters > 3 > cash Flow > cash From Operations
-26577000
Quarters > 3 > cash Flow > capital Expenditures
63000
Quarters > 3 > cash Flow > cash From Investing
-63000
Quarters > 3 > cash Flow > cash From Financing
51006000
Quarters > 3 > cash Flow > net Change In Cash
24366000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.17674003710544822
Quarters > 3 > ratios > PB
-0.3372005665628738
Quarters > 3 > ratios > ROE
39.75773225236857
Quarters > 3 > ratios > ROA
-15.188000464198678
Quarters > 3 > ratios > FCF
-26640000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-3.685666851134477
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
7190000
Annuals > 0 > income Statement > gross Profit
-7190000
Annuals > 0 > income Statement > operating Expenses
107208000
Annuals > 0 > income Statement > operating Income
-114398000
Annuals > 0 > income Statement > interest Expense
9277000
Annuals > 0 > income Statement > pretax Income
-148701000
Annuals > 0 > income Statement > net Income
-148701000
Annuals > 0 > income Statement > eps
-1.2550821517486752
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
118479097
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-132234000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-34303000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
44937000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
47859000
Annuals > 0 > balance Sheet > property Plant Equipment
38553000
Annuals > 0 > balance Sheet > total Assets
137872000
Annuals > 0 > balance Sheet > payables
4490000
Annuals > 0 > balance Sheet > short Term Debt
2917000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
190541000
Annuals > 0 > balance Sheet > equity
-52669000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-148701000
Annuals > 0 > cash Flow > depreciation
7190000
Annuals > 0 > cash Flow > change In Working Capital
311000
Annuals > 0 > cash Flow > cash From Operations
-98122000
Annuals > 0 > cash Flow > capital Expenditures
1572000
Annuals > 0 > cash Flow > cash From Investing
-1572000
Annuals > 0 > cash Flow > cash From Financing
114183000
Annuals > 0 > cash Flow > net Change In Cash
14489000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.2550821517486752
Annuals > 0 > ratios > PB
-0.2240505432265659
Annuals > 0 > ratios > ROE
282.3311625434316
Annuals > 0 > ratios > ROA
-107.85438667749796
Annuals > 0 > ratios > FCF
-99694000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
76550000
Annuals > 1 > income Statement > gross Profit
-76550000
Annuals > 1 > income Statement > operating Expenses
23497000
Annuals > 1 > income Statement > operating Income
-100047000
Annuals > 1 > income Statement > interest Expense
6599000
Annuals > 1 > income Statement > pretax Income
-110776000
Annuals > 1 > income Statement > net Income
-110776000
Annuals > 1 > income Statement > eps
-1.0711249765253876
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
103420238
Annuals > 1 > income Statement > income Tax Expense
3107000
Annuals > 1 > income Statement > EBITDA
-96458000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-10729000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
80448000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
83278000
Annuals > 1 > balance Sheet > property Plant Equipment
44104000
Annuals > 1 > balance Sheet > total Assets
128223000
Annuals > 1 > balance Sheet > payables
6490000
Annuals > 1 > balance Sheet > short Term Debt
2560000
Annuals > 1 > balance Sheet > long Term Debt
38600000
Annuals > 1 > balance Sheet > total Liabilities
114677000
Annuals > 1 > balance Sheet > equity
13546000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-110776000
Annuals > 1 > cash Flow > depreciation
7719000
Annuals > 1 > cash Flow > change In Working Capital
6571000
Annuals > 1 > cash Flow > cash From Operations
-73305000
Annuals > 1 > cash Flow > capital Expenditures
2280000
Annuals > 1 > cash Flow > cash From Investing
-173000
Annuals > 1 > cash Flow > cash From Financing
4507000
Annuals > 1 > cash Flow > net Change In Cash
-69180000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.0711249765253876
Annuals > 1 > ratios > PB
0.7604204713420936
Annuals > 1 > ratios > ROE
-817.7764653772332
Annuals > 1 > ratios > ROA
-86.39323678279248
Annuals > 1 > ratios > FCF
-75585000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1565000
Annuals > 2 > income Statement > cost Of Revenue
8255000
Annuals > 2 > income Statement > gross Profit
-6690000
Annuals > 2 > income Statement > operating Expenses
77888000
Annuals > 2 > income Statement > operating Income
-84578000
Annuals > 2 > income Statement > interest Expense
6200000
Annuals > 2 > income Statement > pretax Income
-11965000
Annuals > 2 > income Statement > net Income
-11965000
Annuals > 2 > income Statement > eps
-0.11610714602269319
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
103051366
Annuals > 2 > income Statement > income Tax Expense
-76184000
Annuals > 2 > income Statement > EBITDA
-76368000
Annuals > 2 > income Statement > operating Margin
-5404.345047923323
Annuals > 2 > income Statement > total Other Income Expense Net
72613000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
149772000
Annuals > 2 > balance Sheet > short Term Investments
2107000
Annuals > 2 > balance Sheet > receivables
31000
Annuals > 2 > balance Sheet > inventories
-31000
Annuals > 2 > balance Sheet > total Current Assets
154208000
Annuals > 2 > balance Sheet > property Plant Equipment
50094000
Annuals > 2 > balance Sheet > total Assets
204302000
Annuals > 2 > balance Sheet > payables
1595000
Annuals > 2 > balance Sheet > short Term Debt
10877000
Annuals > 2 > balance Sheet > long Term Debt
20336000
Annuals > 2 > balance Sheet > total Liabilities
87374000
Annuals > 2 > balance Sheet > equity
116928000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-11965000
Annuals > 2 > cash Flow > depreciation
8210000
Annuals > 2 > cash Flow > change In Working Capital
1029000
Annuals > 2 > cash Flow > cash From Operations
-71129000
Annuals > 2 > cash Flow > capital Expenditures
1048000
Annuals > 2 > cash Flow > cash From Investing
4845000
Annuals > 2 > cash Flow > cash From Financing
-1446000
Annuals > 2 > cash Flow > net Change In Cash
-67730000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.11610714602269319
Annuals > 2 > ratios > PB
0.08777979657224959
Annuals > 2 > ratios > ROE
-10.232792829775589
Annuals > 2 > ratios > ROA
-5.856526123092285
Annuals > 2 > ratios > FCF
-72177000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-46.11948881789137
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1263000
Annuals > 3 > income Statement > cost Of Revenue
61341000
Annuals > 3 > income Statement > gross Profit
-60078000
Annuals > 3 > income Statement > operating Expenses
21130000
Annuals > 3 > income Statement > operating Income
-81208000
Annuals > 3 > income Statement > interest Expense
4348000
Annuals > 3 > income Statement > pretax Income
-26477000
Annuals > 3 > income Statement > net Income
-26477000
Annuals > 3 > income Statement > eps
-0.662415220383845
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
39970398
Annuals > 3 > income Statement > income Tax Expense
-64013000
Annuals > 3 > income Statement > EBITDA
-72967000
Annuals > 3 > income Statement > operating Margin
-6429.770387965162
Annuals > 3 > income Statement > total Other Income Expense Net
54731000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
217502000
Annuals > 3 > balance Sheet > short Term Investments
8000000
Annuals > 3 > balance Sheet > receivables
176000
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
229340000
Annuals > 3 > balance Sheet > property Plant Equipment
57193000
Annuals > 3 > balance Sheet > total Assets
286533000
Annuals > 3 > balance Sheet > payables
2094000
Annuals > 3 > balance Sheet > short Term Debt
2026000
Annuals > 3 > balance Sheet > long Term Debt
27361000
Annuals > 3 > balance Sheet > total Liabilities
164359000
Annuals > 3 > balance Sheet > equity
122174000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-26477000
Annuals > 3 > cash Flow > depreciation
8241000
Annuals > 3 > cash Flow > change In Working Capital
-557000
Annuals > 3 > cash Flow > cash From Operations
-81190000
Annuals > 3 > cash Flow > capital Expenditures
220000
Annuals > 3 > cash Flow > cash From Investing
-8220000
Annuals > 3 > cash Flow > cash From Financing
266983000
Annuals > 3 > cash Flow > net Change In Cash
177573000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.662415220383845
Annuals > 3 > ratios > PB
0.03258509699936157
Annuals > 3 > ratios > ROE
-21.671550411707894
Annuals > 3 > ratios > ROA
-9.240471429119857
Annuals > 3 > ratios > FCF
-81410000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-64.45764053840064
Annuals > 3 > health Score
24
Valuation > metrics > PE
-0.11060347491988828
Valuation > metrics > PB
-4.994982565986108
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
368.5539886339718
Profitability > metrics > ROA
-42.344804236898746
Profitability > metrics > Net Margin
-23.253652058432934
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-9.337672281776417
Risk > final Score
-7
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.3769701919150674
Liquidity > metrics > Quick Ratio
1.8728460596161698
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
22.4973983905228
Prev Valuations > 1
90
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
100
Prev Profitabilities > 2
40
Prev Risks > 0
-41
Prev Risks > 1
-25
Prev Risks > 2
-15
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:59:47.604Z
Earnings History > 0 > period
2021-06-30
Earnings History > 0 > report Date
2021-09-30
Earnings History > 0 > date
2021-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.7181
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.7181
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.7598
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.7598
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.9075
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.9075
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-06-30
Earnings History > 3 > report Date
2020-09-30
Earnings History > 3 > date
2020-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-3.0683
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-3.0683
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-03-31
Earnings History > 4 > report Date
2020-06-30
Earnings History > 4 > date
2020-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.676
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.676
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2019-12-31
Earnings History > 5 > report Date
2020-03-31
Earnings History > 5 > date
2019-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.8145
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.8145
Earnings History > 5 > surprise Percent
-
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADowngrade Watch: Is FCRX stock a good pick for beginners - July 2025 Selloffs & Safe Entry Point Alerts baoquankhu1.vn
Read more →Will HUMAW stock benefit from commodity prices - Bullish Engulfing Patterns & Access Free Risk Analysis Before You Invest bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Humacyte Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-06-30
EPS Actual
-0.7181
EPS Estimate
0
EPS Difference
-0.7181
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.